In order to effectively coordinate our social responsibility activities and sustainability efforts, Richter's Board of Directors established a three-person ESG Subcommittee in December 2021. The task of the Subcommittee is to continuously monitor the ESG requirements as determined by domestic and international capital markets and to make recommendations to the Board of Directors in order for Richter to comply with those requirements. [...] Due to the increased risk of corruption, the Richter Group does not support political parties, does not engage in lobbying activities and does not influence the financial decisions of national governments. There are strict rules on relations and cooperation with public sector employees and government officials at Richter. At the same time, the Richter Group naturally seeks to participate as much as it can in the consultation process on legislation affecting the pharmaceutical industry. This is typically done in coordination with industry trade associations, chambers and federations. The most important organisation in Hungary is the National Association of Hungarian Pharmaceutical Manufacturers (MAGYOSZ), while in Europe it is Medicines for Europe.